Skip to main content
logo
NeuroPace, Inc. (NPCE)
NASDAQ: NPCE · Real-Time Price · USD
16.28
+0.01 (0.06%)
At close: May 21, 2026, 4:00 PM EDT
16.32
+0.04 (0.25%)
After-hours: May 21, 2026, 6:10 PM EDT

NeuroPace Revenue

NeuroPace had revenue of $22.07M in the quarter ending March 31, 2026, a decrease of -2.02%. This brings the company's revenue in the last twelve months to $99.53M, up 18.06% year-over-year. In the year 2025, NeuroPace had annual revenue of $99.99M with 25.13% growth.

Revenue (ttm)
$99.53M
Revenue Growth
+18.06%
P/S Ratio
5.58
Revenue / Employee
$452,409
Employees
220
Market Cap
555.05M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202599.99M20.08M25.13%
Dec 31, 202479.91M14.49M22.14%
Dec 31, 202365.42M19.90M43.72%
Dec 31, 202245.52M337.00K0.75%
Dec 31, 202145.18M4.05M9.83%
Dec 31, 202041.14M4.17M11.27%
Dec 31, 201936.97M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Varex Imaging857.50M
Orthofix Medical825.37M
Tactile Systems Technology343.52M
OrthoPediatrics243.30M
Cerus216.56M
SI-BONE206.22M
Cytek Biosciences204.17M
Beta Bionics110.24M
Revenue Rankings

NPCE News

More News